Doxorubicin Penetration
Doxorubicin Penetration - Related Videos
09:56
Preparation and Characterization of Lipophilic Doxorubicin Pro-drug Micelles
0 Views •
Cited by 22 •
2016
A protocol for the preparation and characterization of lipophilic doxorubicin pro-drug loaded 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[amino(polyethylene glycol)-2000] (DSPE-PEG) micelles is described.
10:12
Construction of Cyclic Cell-Penetrating Peptides for Enhanced Penetration of Biological Barriers
0 Views •
Cited by 5 •
2022
This protocol describes the synthesis of cyclic cell-penetrating peptides with aromatic cross-links and the evaluation of their permeability across biological barriers.
08:57
Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice
0 Views •
Cited by 8 •
2017
This protocol describes an efficient and convenient analytical process of sample extraction and simultaneous determination of multiple drugs, doxorubicin (DOX), mitomycin C (MMC) and a cardio-toxic DOX metabolite, doxorubicinol (DOXol), in the biological samples from a preclinical breast tumor model treated with nanoparticle formulations of synergistic drug combination.
08:39
Shifting Zebrafish Lethal Skeletal Mutant Penetrance by Progeny Testing
0 Views •
Cited by 8 •
2017
The goal of this protocol is to alter the penetrance of lethal skeletal mutant phenotypes in zebrafish by selective breeding. Lethal mutants cannot be grown to adulthood and bred themselves, therefore this protocol describes a method for tracking and selecting penetrance through multiple generations by progeny testing.
03:30
Inducing Penetrating Traumatic Brain Injury in Adult Drosophila Flies
0 Views •
2025
This video demonstrates the induction of penetrating traumatic brain injury in the drosophila brain. Newly emerged flies are selected, anesthetized, and positioned under a fluorescence-equipped stereo microscope. The GFP-expressing mushroom body is identified, and a Minutien pin is inserted to cause injury. The flies are allowed to recover for further studies.
FAQs
A concentration gradient supplies the driving force for doxorubicin movement, while diffusion determines how the drug spreads from regions of higher concentration toward regions of lower concentration. The resulting distribution depends on how far the drug can travel before encountering tissue or material barriers. Mapping this process helps determine whether target cells receive sufficient exposure rather than only measuring the applied dose.
Dense extracellular matrix can restrict doxorubicin movement by reducing the available pathways through tissue, whereas interstitial flow can alter its distribution through the local environment. These factors make penetration spatially uneven and help explain why cells at different locations may experience different exposure levels. Bioengineered models can isolate these transport barriers when researchers evaluate delivery performance.
Doxorubicin interactions with cells can alter how much drug remains available to move through surrounding tissue or biomaterial. Consequently, the concentration applied at the model boundary may not represent exposure at every cellular location. Relating spatial drug distribution to cytotoxic responses allows researchers to distinguish limited transport from differences in how target cells respond to the delivered compound.
Total dose does not reveal whether doxorubicin reaches target cells throughout a tissue or remains concentrated near the delivery site. Penetration analysis adds spatial information about exposure, including regions that may receive less drug because of tissue architecture, matrix density, flow, or cellular interactions. This distinction is important when interpreting cytotoxic outcomes and assessing treatment effectiveness.
Researchers expose tumor spheroids or tissue models to doxorubicin, examine how the drug distributes through the model, and relate that spatial pattern to cellular cytotoxic responses. The comparison identifies whether limited penetration corresponds to reduced effects in less-exposed regions. Such measurements provide a transport-focused assessment of model behavior rather than relying only on the initial treatment concentration.
Engineered biomaterials provide controlled environments for evaluating how material structure influences doxorubicin movement. By studying distribution through these systems, researchers can identify transport barriers and assess designs intended to improve local delivery. The resulting information supports development of delivery platforms that place drug exposure closer to target tissue while helping address unwanted exposure outside the intended region.
Penetration studies connect transport conditions with the spatial pattern of doxorubicin exposure and the resulting cytotoxic response. Incorporating tissue architecture, extracellular matrix density, interstitial flow, and cellular interactions makes tumor spheroids, tissue models, and delivery systems more representative of transport challenges. These platforms can then support optimization of treatment efficacy and evaluation of potential off-target toxicity.